These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 25300936)

  • 1. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study.
    Al-Chalabi A; Calvo A; Chio A; Colville S; Ellis CM; Hardiman O; Heverin M; Howard RS; Huisman MHB; Keren N; Leigh PN; Mazzini L; Mora G; Orrell RW; Rooney J; Scott KM; Scotton WJ; Seelen M; Shaw CE; Sidle KS; Swingler R; Tsuda M; Veldink JH; Visser AE; van den Berg LH; Pearce N
    Lancet Neurol; 2014 Nov; 13(11):1108-1113. PubMed ID: 25300936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyotrophic lateral sclerosis as a multi-step process: an Australia population study.
    Vucic S; Westeneng HJ; Al-Chalabi A; Van Den Berg LH; Talman P; Kiernan MC
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 Nov; 20(7-8):532-537. PubMed ID: 31284763
    [No Abstract]   [Full Text] [Related]  

  • 3. The multistep hypothesis of ALS revisited: The role of genetic mutations.
    Chiò A; Mazzini L; D'Alfonso S; Corrado L; Canosa A; Moglia C; Manera U; Bersano E; Brunetti M; Barberis M; Veldink JH; van den Berg LH; Pearce N; Sproviero W; McLaughlin R; Vajda A; Hardiman O; Rooney J; Mora G; Calvo A; Al-Chalabi A
    Neurology; 2018 Aug; 91(7):e635-e642. PubMed ID: 30045958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor Neuron Disease Register for England, Wales and Northern Ireland-an analysis of incidence in England.
    Opie-Martin S; Ossher L; Bredin A; Kulka A; Pearce N; Talbot K; Al-Chalabi A
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Feb; 22(1-2):86-93. PubMed ID: 32940088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALS is a multistep process in South Korean, Japanese, and Australian patients.
    Vucic S; Higashihara M; Sobue G; Atsuta N; Doi Y; Kuwabara S; Kim SH; Kim I; Oh KW; Park J; Kim EM; Talman P; Menon P; Kiernan MC;
    Neurology; 2020 Apr; 94(15):e1657-e1663. PubMed ID: 32071166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over.
    Forbes RB; Colville S; Swingler RJ;
    Age Ageing; 2004 Mar; 33(2):131-4. PubMed ID: 14960427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease, psychiatric diagnosis and sex differences in the multistep hypothesis of amyotrophic lateral sclerosis.
    Garton FC; Trabjerg BB; Wray NR; Agerbo E
    Eur J Neurol; 2021 Feb; 28(2):421-429. PubMed ID: 32978838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry).
    Abhinav K; Stanton B; Johnston C; Hardstaff J; Orrell RW; Howard R; Clarke J; Sakel M; Ampong MA; Shaw CE; Leigh PN; Al-Chalabi A
    Neuroepidemiology; 2007; 29(1-2):44-8. PubMed ID: 17898523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Previous psychiatric disorders in the multistep hypothesis of amyotrophic lateral sclerosis: a South Korean population study.
    Choi SJ; Park CHK; Hong YH; Sung JJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Nov; 23(7-8):601-607. PubMed ID: 35164606
    [No Abstract]   [Full Text] [Related]  

  • 10. Associations of Electric Shock and Extremely Low-Frequency Magnetic Field Exposure With the Risk of Amyotrophic Lateral Sclerosis.
    Peters S; Visser AE; D'Ovidio F; Beghi E; Chiò A; Logroscino G; Hardiman O; Kromhout H; Huss A; Veldink J; Vermeulen R; van den Berg LH;
    Am J Epidemiol; 2019 Apr; 188(4):796-805. PubMed ID: 30649156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study.
    Logroscino G; Beghi E; Zoccolella S; Palagano R; Fraddosio A; Simone IL; Lamberti P; Lepore V; Serlenga L;
    J Neurol Neurosurg Psychiatry; 2005 Aug; 76(8):1094-8. PubMed ID: 16024886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secular Trends of Amyotrophic Lateral Sclerosis: The Piemonte and Valle d'Aosta Register.
    Chiò A; Mora G; Moglia C; Manera U; Canosa A; Cammarosano S; Ilardi A; Bertuzzo D; Bersano E; Cugnasco P; Grassano M; Pisano F; Mazzini L; Calvo A;
    JAMA Neurol; 2017 Sep; 74(9):1097-1104. PubMed ID: 28692730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of amyotrophic lateral sclerosis in Rhineland-Palatinate, Germany.
    Wolf J; Wöhrle JC; Palm F; Nix WA; Maschke M; Safer A; Becher H; Grau AJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Jun; 15(3-4):269-74. PubMed ID: 24571628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical epidemiology of amyotrophic lateral sclerosis in Liguria, Italy: An update of LIGALS register.
    Scialò C; Novi G; Bandettini di Poggio M; Canosa A; Sormani MP; Mandich P; Origone P; Truffelli R; Mancardi GL; Caponnetto C
    Amyotroph Lateral Scler Frontotemporal Degener; 2016; 17(7-8):535-542. PubMed ID: 27399231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irish Amyotrophic Lateral Sclerosis Incidence: Age, Period, and Cohort Effects Using a Partial Least Squares Regression Model.
    McFarlane R; Heverin M; Walsh C; Hardiman O
    Neurology; 2024 Jun; 102(11):e209391. PubMed ID: 38728654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between ALS and population density: A population based study.
    Scott KM; Abhinav K; Wijesekera L; Ganesalingam J; Goldstein LH; Janssen A; Dougherty A; Willey E; Stanton BR; Turner MR; Ampong MA; Sakel M; Orrell R; Howard R; Shaw CE; Nigel Leigh P; Al-Chalabi A
    Amyotroph Lateral Scler; 2010 Oct; 11(5):435-8. PubMed ID: 20429684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical activity and amyotrophic lateral sclerosis: a European population-based case-control study.
    Pupillo E; Messina P; Giussani G; Logroscino G; Zoccolella S; Chiò A; Calvo A; Corbo M; Lunetta C; Marin B; Mitchell D; Hardiman O; Rooney J; Stevic Z; Bandettini di Poggio M; Filosto M; Cotelli MS; Perini M; Riva N; Tremolizzo L; Vitelli E; Damiani D; Beghi E;
    Ann Neurol; 2014 May; 75(5):708-16. PubMed ID: 24706338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing picture of amyotrophic lateral sclerosis: lessons from European registers.
    Hardiman O; Al-Chalabi A; Brayne C; Beghi E; van den Berg LH; Chio A; Martin S; Logroscino G; Rooney J
    J Neurol Neurosurg Psychiatry; 2017 Jul; 88(7):557-563. PubMed ID: 28285264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentre, cross-cultural, population-based, case-control study of physical activity as risk factor for amyotrophic lateral sclerosis.
    Visser AE; Rooney JPK; D'Ovidio F; Westeneng HJ; Vermeulen RCH; Beghi E; Chiò A; Logroscino G; Hardiman O; Veldink JH; van den Berg LH;
    J Neurol Neurosurg Psychiatry; 2018 Aug; 89(8):797-803. PubMed ID: 29685899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study.
    Scott KM; Abhinav K; Stanton BR; Johnston C; Turner MR; Ampong MA; Sakel M; Orrell RW; Howard R; Shaw CE; Leigh PN; Al-Chalabi A
    Neuroepidemiology; 2009; 32(2):81-8. PubMed ID: 19039239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.